CTCSX | VISGX | CTCSX / VISGX | |
Total Expense Ratio | 2.05 | 0.19 | 1,079% |
Annual Report Gross Expense Ratio | 2.10 | 0.19 | 1,105% |
Fund Existence | 4 years | 27 years | - |
Gain YTD | 15.582 | 6.198 | 251% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 521M | 38.6B | 1% |
Annual Yield % from dividends | 1.61 | 0.40 | 399% |
Returns for 1 year | 33.93 | 18.17 | 187% |
Returns for 3 years | 62.68 | 42.48 | 148% |
Returns for 5 years | N/A | 41.95 | - |
Returns for 10 years | N/A | 141.02 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 70.31 | 1.02 | +1.48% |
Virtus LifeSci Biotech Products ETF | |||
NUDM | 36.81 | 0.20 | +0.55% |
Nuveen ESG Intl Dev Mkts Eq ETF | |||
FLUD | 25.05 | 0.04 | +0.15% |
Franklin Ultra Short Bond ETF | |||
SHYG | 43.13 | 0.02 | +0.05% |
iShares 0-5 Year High Yield Corp Bd ETF | |||
MLPD | 25.41 | -0.02 | -0.07% |
Global X MLP & Engy Infras Cov Cll ETF |